The Cigna Group (CI) investor relations material

Executive summary

• Q2 2026 revenues rose 7% year-over-year to $71.7 billion, with strong performance in both Evernorth and Cigna Healthcare segments.

• Adjusted income from operations for Q2 2026 was $2.1 billion ($7.78 per share), up 6% year-over-year.

• Shareholders' net income for Q2 2026 was $1.66 billion–$1.7 billion, with diluted EPS up 10% year-over-year.

• Full-year 2026 adjusted EPS outlook raised to at least $30.45, reflecting confidence in ongoing execution.

• Continued focus on innovation, leveraging AI and technology to enhance personalized healthcare and operational efficiency.

Financial highlights

• Q2 2026 total revenues: $71.7 billion; adjusted after-tax earnings: $2.1 billion; adjusted EPS: $7.78.

• Evernorth revenues grew 6% year-over-year to $61.5 billion; pre-tax adjusted earnings: $1.7 billion.

• Cigna Healthcare revenues up 9%–10% year-over-year to $11.8 billion; pre-tax adjusted earnings: $1.3 billion.

• Specialty and Care Services pre-tax adjusted earnings up 22% year-over-year to $1.1 billion.

• After-tax special item charges of $153 million ($0.58 per share) recorded in Q2.

Outlook and guidance

• Full-year 2026 adjusted EPS outlook increased to at least $30.45.

• Evernorth full-year pre-tax adjusted earnings expected at least $6.9 billion; Cigna Healthcare at least $4.55 billion.

• Second half adjusted EPS expected to be split evenly between Q3 and Q4.

• Cigna Healthcare Medical Care Ratio (MCR) forecasted between 83.7% and 84.7% for 2026; Q3 MCR expected slightly above Q2.

• Outlook includes anticipated share repurchases and 2026 dividends.